Brian Silver

Chief Financial Officer & Head of Corporate Development at Freeline Therapeutics Ltd.

Brian Silver

Brian Silver

Chief Financial Officer & Head of Corporate Development at Freeline Therapeutics Ltd.

Biography

Prior to joining Perella Weinberg Partners, Mr. Silver was a Managing Director in Morgan Stanley’s Healthcare Investment Banking Group, where he advised a broad range of biopharmaceutical and pharmaceutical services clients on mergers and acquisitions, initial public offerings, the equity and debt capital markets, and royalty financing. During his tenure at Morgan Stanley, Mr. Silver advised on a number of significant transactions, including Mylan Inc.’s $1.6 billion acquisition of Agila Specialties Private Limited; Quintiles Transnational Holdings, Inc.’s $1.1 billion initial public offering; The Carlyle Group and Hellman & Friedman’s $3.9 billion acquisition of Pharmaceutical Product Development, Inc.; three landmark financings totaling $320 million for Synageva Biopharma Corp.; and New York University’s sale of its worldwide royalty interest in Remicade to Royalty Pharma for $650 million.

Prior to joining Morgan Stanley in 1998, Mr. Silver was an M&A Associate at Sullivan & Cromwell and an M&A investment banker at Salomon Brothers.

Mr. Silver received a Bachelor of Arts with honors in Social Studies from Harvard College and a Juris Doctor with honors from the University of Chicago Law School.

Overview
Career Highlights

Freeline Therapeutics Ltd.

RelSci Relationships

436

Number of Boards

1

Relationships
RelSci Relationships are individuals Brian Silver likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Freeline Therapeutics Ltd.

Relationship likelihood: Strong

Partner at Syncona Partners LLP

Relationship likelihood: Strong

Director at Galapagos Conservancy, Inc.

Relationship likelihood: Strong

Founder at The Biological Dynamics of Forest Fragmentation Project

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Managing Director, Investment & Portfolio Management at NGEN Partners LLC

Relationship likelihood: Strong

Co-Founder at International Crane Foundation

Relationship likelihood: Strong

Former President, Government Relations Task Force at Bank Street College of Education

Relationship likelihood: Strong

Director at Livingston Ripley Waterfowl Conservancy, Inc.

Relationship likelihood: Strong

Former Member, Board of Directors at Livingston Ripley Waterfowl Conservancy, Inc.

Relationship likelihood: Strong

Paths to Brian Silver
Potential Connections via
Relationship Science
You
Brian Silver
Chief Financial Officer & Head of Corporate Development at Freeline Therapeutics Ltd.
Career History
Chief Financial Officer & Head of Corporate Development
2018 - Current

Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders. It develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom.

Partner, Advisory
2013 - Prior

Perella Weinberg Partners is a leading independent financial services firm. Established in 2006, the Firm provides advisory and asset management services to a global client base, including corporations, institutions and governments. The Advisory business advises clients on mergers and acquisitions, financial restructuring, capital structure advisory, private capital raising, pension matters, strategic advisory, independent special committee advisory, and government services. The Asset Management business includes a suite of hedge fund strategies, private investment funds and outsourced investment office solutions. Including affiliates, Perella Weinberg Partners has capital commitments and managed assets of more than $8.9 billion. Serving a diverse group of global clients, Perella Weinberg Partners employs over 415 employees located in our New York, London, Abu Dhabi, Austin, Beijing, Denver, Dubai, and San Francisco offices. The firm is a subsidiary of Perella Weinberg Partners Group LP.

Professional
Prior

Founded in 1969, Morgan Stanley & Co. LLC is an SEC-registered broker/dealer headquartered in New York City. The firm is the primary broker subsidiary of Morgan Stanley (NYSE: MS). They are a member of FINRA. Morgan Stanley & Co. provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.The firm's Sales & Trading division offers cash and electronic trading platforms where Morgan Stanley acts as principal (including as a market maker) and agent in executing transactions globally in equity and equity-related products. These products include equity swaps, options, warrants and futures overlying individual securities, indices and baskets of securities and other equity-related products. Morgan Stanley's Institutional Equity division is a global leader in the origination, distribution and trading of equity, equity-linked and equity-derivative securities. Their Fixed Income team deals in a diverse range of products including interest rate and currency products, credit products, derivatives and commodities.

Boards & Committees
Member, Board of Directors
Current

The Conservancy has a three-fold mission which includes research, education and conservation action. Each program benefits from and compliments the others while furthering LRWC’s mission of protecting waterfowl and wetlands. All three programs integrate the Conservancy’s historical and present-day connection to aviculture while furthering the collective knowledge, awareness of, and concern for waterfowl and the habitats in which they live.

Transactions
Details Hidden

Synageva BioPharma Corp. issued Common Stock

Details Hidden

Pfizer, Inc. purchases Encysive Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian Silver. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian Silver's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian Silver.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/brian-silver-90235245
  • https://relationshipscience.com/person/brian-silver-90235245